Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 169,788
  • Shares Outstanding, K 41,111
  • Annual Sales, $ 190 K
  • Annual Income, $ -28,210 K
  • 60-Month Beta 2.20
  • Price/Sales 893.25
  • Price/Cash Flow N/A
  • Price/Book 2.63
Trade CRMD with:

Options Overview Details

View History
  • Implied Volatility 100.06% ( -3.89%)
  • Historical Volatility 266.02%
  • IV Percentile 73%
  • IV Rank 18.82%
  • IV High 271.30% on 06/17/22
  • IV Low 60.35% on 01/18/22
  • Put/Call Vol Ratio 0.29
  • Today's Volume 661
  • Volume Avg (30-Day) 1,217
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 18,845
  • Open Int (30-Day) 17,139

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +42.67%
on 08/09/22
8.02 -46.67%
on 08/08/22
-0.33 (-7.16%)
since 07/15/22
3-Month
2.64 +61.81%
on 06/16/22
8.02 -46.67%
on 08/08/22
+0.67 (+18.56%)
since 05/16/22
52-Week
2.64 +61.81%
on 06/16/22
8.02 -46.67%
on 08/08/22
-1.71 (-28.55%)
since 08/16/21

Most Recent Stories

More News
CorMedix Inc Common Stock (CRMD) Q2 2022 Earnings Call Transcript

CRMD earnings call for the period ending June 30, 2022.

CRMD : 4.28 (+3.63%)
CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update

Conference Call Scheduled for Today at 8:30 a.m. Eastern Time...

CRMD : 4.28 (+3.63%)
Why CorMedix Stock Was Plummeting on Tuesday

Bad news on the regulatory front leads investors to bail en masse from the company.

CRMD : 4.28 (+3.63%)
CorMedix Inc. Announces Regulatory and Manufacturing Updates

BERKELEY HEIGHTS, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

CRMD : 4.28 (+3.63%)
CorMedix to Participate at the JMP Securities Life Sciences Conference

BERKELEY HEIGHTS, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

CRMD : 4.28 (+3.63%)
CorMedix Inc Common Stock (CRMD) Q1 2022 Earnings Call Transcript

CRMD earnings call for the period ending March 31, 2022.

CRMD : 4.28 (+3.63%)
CorMedix (CRMD) Reports Q1 Loss, Lags Revenue Estimates

CorMedix (CRMD) delivered earnings and revenue surprises of 21.74% and 84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CRMD : 4.28 (+3.63%)
HOOK : 1.7300 (+0.29%)
CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time...

CRMD : 4.28 (+3.63%)
CorMedix Inc. Announces Leadership Updates and Operational Changes

BERKELEY HEIGHTS, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

CRMD : 4.28 (+3.63%)
Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates

Adma Biologics (ADMA) delivered earnings and revenue surprises of -25% and 9.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ADMA : 2.40 (-0.41%)
CRMD : 4.28 (+3.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 4.82
2nd Resistance Point 4.59
1st Resistance Point 4.43
Last Price 4.28
1st Support Level 4.04
2nd Support Level 3.81
3rd Support Level 3.65

See More

52-Week High 8.02
Fibonacci 61.8% 5.97
Fibonacci 50% 5.34
Fibonacci 38.2% 4.70
Last Price 4.28
52-Week Low 2.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar